comprehensive -WSS

comprehensive

author：entertainment 2025-09-14 08:27:03 - browse：878

De-Shaine Murray is working at the cutting edge of neurotechnology. As a postdoctoral fellow at Yale, he is developing a device to monitor the brain following traumatic brain injury or stroke.

He is also trying to fight the long legacy of racism in neuroscience. During 2020, when it was difficult to conduct research, he said, “I got the chance and the ability to read more widely and to just look into the legacy of neuroscience.” He found a direct line from racist pseudoscience like phrenology to disparities in neuroscience today, like how the texture of Black people’s hair can sometimes exclude them from clinical trials because electrodes are not designed for them. In 2021, he co-founded Black in Neuro, an organization dedicated to improving Black representation in neuroscience.

On this episode of the “First Opinion Podcast,” I spoke to him about how the past and present racism in neuroscience could be reflected in the future, especially as neurotechnology like brain implants become more common.

“I’m not saying that whatever electrode that you made or created is racist. But when you have someone who … creates a technology but doesn’t think about the wide range of users that are potentially going to use it, then that’s where the problem comes in,” he told me.

We also discussed the way inequities in neuroscience research are visible in stroke wards, how brain implants might jump from helping disabled people to being used for human enhancement, and more.

Our conversation was inspired by his recent First Opinion essay, “Neuroscience has to grapple with a long legacy of racism if it wants to move into the future.” The book I mention at the end is “Lock In” by John Scalzi, a great sci-fi mystery exploring themes of race, socioeconomic status, neurotechnology, and more.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

LETTER TO THE EDITOR

Have an opinion on this essay? Submit a letter to the editor here.

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Trump surgeon general acknowledges mistakes during Covid

WSS

How generative AI is inspiring dreams of a health data revolution

Why age limits for politicians are a terrible idea

Analysis of telehealth claims data suggest service duplication

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Sana to lay off nearly a third of staff, de

AI can decode, harness the power of the humane immune system

knowledge

comprehensive

LETTER TO THE EDITOR

Have an opinion on this essay? Submit a letter to the editor here.

hotspot

Apple is now the first public company to be valued at $3 trillion

Snackable artificial intelligence, expert AI, and the pharma industry

Medicare details structure of new drug price negotiation program

3 questions for the future of Biden's cancer moonshot

Alkermes shareholders re

Humana sues Biden admin over Medicare Advantage audit rule

Walensky prepares to leave CDC — and Congress — behind

3 questions for the future of Biden's cancer moonshot

Alkermes shareholders re

Analysis of telehealth claims data suggest service duplication

focus

3 questions for the future of Biden's cancer moonshot

House transparency, PBM reform bill gains bipartisan support

The 10 drugs up first for Medicare price negotiation

FDA authorizes Novavax’s updated Covid

Senate panel eyes new effort on drug shortages

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

knowledge

hotspot

hotspot

entertainment